Background HPV is a major cancer-causing factor in both sexes in the cervix, vulva, vagina,
anus, penis, oropharynx as well as the causal factor in other diseases such as genital warts …

Introduction Persistent infections with human papillomavirus (HPV) are a necessary cause of
cervical cancer and are responsible for important morbidity in men and women. Since 2007 …

Abstract Background In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is
offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine …

Objective The purpose of this study was to assess the consequences of a national
immunization program with HPV vaccine for both boys and girls in Denmark, including the …

The International Agency for Research on Cancer acknowledges that HPV is a human
carcinogen affecting both sexes. This study aimed to evaluate the public health impact of …

To assess the epidemiological and economic impact of alternative quadrivalent human
papillomavirus (HPV) vaccine strategies in Norway, we adapted a previously published …

Human papillomavirus (HPV) is one of the main causes of infection-related cancer. The
bivalent vaccine (2vHPV)(16/18) and quadrivalent (6/11/16/18) HPV vaccine (4vHPV) have …

Background An infection with high-risk human papillomavirus (HPV) is the obligatory
aetiological factor for the development of cervical cancer. In Switzerland, the prevention …

Background HPV is related to a number of cancer types, causing a considerable burden in
both genders in Europe. Female vaccination programs can substantially reduce the …

Objective: Based on positive safety and efficacy data, a quadrivalent Human PapillomaVirus
(HPV) vaccine has been approved in Switzerland to prevent HPV types 6, 11, 16 and 18 …